Who owns Q32 BIO INC COM?
- Ticker: QTTB
- CUSIP Number: 746964105
Tip: Access positions for across all investors
Analyze quarterly positions in Q32 Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Top investors of Q32 Bio stock
Who bought or sold Q32 BIO INC COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 2.3M | $40M | 0% | Jun 2024 |
|
Atlas Venture Life Science Advisors | 2.1M | $38M | 0% | Jun 2024 |
|
Carlyle | 1.1M | $19M | 0% | Jun 2024 |
|
Vivo Capital | 370k | $6.3M | 100% | Mar 2024 |
|
BlackRock | 342k | $6.1M | 668% | Jun 2024 |
|
Arch Venture Corp | 321k | $5.8M | 0% | Jun 2024 |
|
Temasek Holdings | 314k | $5.3M | 100% | Mar 2024 |
|
5AM Venture Management | 252k | $4.5M | 0% | Jun 2024 |
|
ADAR1 Capital Management | 188k | $3.2M | 100% | Mar 2024 |
|
Harvard Management Company | 163k | $2.9M | 100% | Jun 2024 |
|
Vanguard Group | 138k | $2.5M | 28% | Jun 2024 |
|
Platinum Investment Mangement | 110k | $1.9M | 100% | Mar 2024 |
|
Ikarian Capital | 109k | $2.0M | 388% | Jun 2024 |
|
Geode Capital Management | 108k | $1.9M | 499% | Jun 2024 |
|
State Street Corporation | 81k | $1.5M | 100% | Jun 2024 |
|
Ensign Peak Advisors | 65k | $1.2M | 151% | Jun 2024 |
|
Exome Asset Management | 44k | $787k | -33% | Jun 2024 |
|
Affinity Asset Advisors | 28k | $499k | 0% | Jun 2024 |
|
Citadel Advisors | 18k | $328k | 63% | Jun 2024 |
|
Bank of New York Mellon | 18k | $315k | 100% | Jun 2024 |
|
Charles Schwab Investment Management | 15k | $277k | 100% | Jun 2024 |
|
Springbok Capital Management | 15k | $258k | 100% | Mar 2024 |
|
Renaissance Technologies | 15k | $265k | 100% | Jun 2024 |
|
Bank of America Corporation | 13k | $239k | 42% | Jun 2024 |
|
Goldman Sachs Group | 12k | $214k | 100% | Jun 2024 |
|
Rhumbline Advisers | 7.7k | $138k | 11682% | Jun 2024 |
|
Morgan Stanley | 6.8k | $121k | 835% | Jun 2024 |
|
New York State Common Retirement Fund | 6.6k | $118k | 100% | Jun 2024 |
|
Barclays | 5.1k | $93k | 71% | Jun 2024 |
|
FMR | 3.5k | $60k | 100% | Mar 2024 |
|
Wells Fargo & Company | 2.7k | $49k | 3352% | Jun 2024 |
|
Jpmorgan Chase & Co | 2.6k | $47k | 5037% | Jun 2024 |
|
Tower Research Capital | 2.2k | $40k | 100% | Jun 2024 |
|
Citigroup | 1.4k | $24k | 100% | Jun 2024 |
|
UBS Group | 940.00 | $16k | 100% | Mar 2024 |
|
Royal Bank of Canada | 622.00 | $11k | 1031% | Jun 2024 |
|
Summit Investment Advisors | 591.00 | $11k | 100% | Jun 2024 |
|
Redwood Wealth Management Group | 511.00 | $9.2k | 100% | Jun 2024 |
|
California State Teachers Retirement System | 437.00 | $7.8k | 100% | Jun 2024 |
|
Bnp Paribas Arbitrage, Snc | 434.00 | $7.8k | 100% | Jun 2024 |
|
Amalgamated Bank | 209.00 | $4.0k | 100% | Jun 2024 |
|
Federation des caisses Desjardins du Quebec | 39.00 | $699.999300 | 0% | Jun 2024 |
|
Goss Wealth Management | 22.00 | $394.999000 | -12% | Jun 2024 |
|
Global Retirement Partners | 16.00 | $287.000000 | 100% | Jun 2024 |
|
Advisor Group Holdings | 15.00 | $255.000000 | 100% | Mar 2024 |
|
AdvisorNet Financial | 13.00 | $233.000300 | -71% | Jun 2024 |
|
Harbour Investments | 11.00 | $197.000100 | 100% | Jun 2024 |
|
D. J. St. Germain | 11.00 | $197.000100 | 0% | Jun 2024 |
|
BFSG | 11.00 | $198.000000 | 0% | Jun 2024 |
|
Thompson Investment Management | 4.00 | $72.000000 | 0% | Jun 2024 |
|
Who sold out of Q32 Bio?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
BML Capital Management | Mar 2024 | 25k | $424k |
Woodline Partners | Mar 2024 | 16k | $266k |
Acadian Asset Management | Mar 2024 | 3.7k | $62k |